[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

2017-2022 Global and Japan Urinary System Drugs Market Analysis Report

August 2017 | 122 pages | ID: 2CAF009C129EN
JP Research

US$ 3,085.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Urinary System Drugs market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2017, growing at a CAGR of XX% between 2016 and 2022.

Japan plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2017, with a CAGR of xx%.

This report, with focus on top players in the global and Japan, studies the Urinary System Drugs market's development status and future trend in the global and Japan. It splits Urinary System Drugs market by type and by applications to fully and deeply research and reveal market profile and prospect.

The major players include
  • ALEMBIC PHARMACEUTICALS LIMITED IN 390 003 Vadodara
  • AMRI INDIA PRIVATE LIMITED IN 431 136 Aurangabad
  • AREVIPHARMA GMBH DE 01445 Radebeul
  • AURISCO PHARMACEUTICAL CO., LTD. CN 317 200 Tiantai
  • AUROBINDO PHARMA LIMITED IN 500 038 Hyderabad
  • Bioindustria L.I.M. S.p.A. IT 15067 Novi Ligure
  • BLUE CIRCLE ORGANICS PRIVATE LIMITED IN 421 501 Ambernath West
  • Cambrex Charles City, Inc. US 50616-3466 Charles City
  • CARGILL S.R.L. DIVISIONE AMIDI DERIVATI SPECIALITA IT 45035 Castelmassa
  • CKD BIO CORPORATION KR 15604 Ansan-si
  • Cosma S.p.A. IT 24040 Ciserano
  • CSPC INNOVATION PHARMACEUTICAL CO., LTD. CN 051 430 Shijiazhuang City
  • CTX LIFE SCIENCES PVT. LIMITED IN 394 230 Surat
  • EDMOND PHARMA S.R.L. IT 20037 Paderno Dugnano
  • F Hoffmann-La Roche Ltd. CH 4070 Basel
  • F.I.S. Fabbrica Italiana Sintetici S.p.A. IT 36075 Montecchio Maggiore
  • FLAMMA S.P.A. IT 24040 Chignolo d'Isola
  • G.D. Searle LLC US 10017 New York City
  • Gedeon Richter Plc. HU 1103 Budapest
  • HARMAN FINOCHEM LIMITED IN 400 098 Mumbai
  • HUBEI BIOCAUSE PHARMACEUTICAL CO., LTD. CN 448 000 Jingmen City
  • Industriale Chimica S.R.L. IT 21047 Saronno
  • IPCA Laboratories Limited IN 400 067 Mumbai
  • Laboratori Alchemia Srl IT 20134 Milano
  • MEDILUX LABORATORIES PRIVATE LIMITED IN 454 775 Pithampur
  • Micronised SANOFI CHIMIE FR 94250 Gentilly
  • Moehs Iberica S.L. ES 08191 Rubi
  • MSN LABORATORIES PRIVATE LIMITED IN 502 329 Rudraram Village
  • NAKODA CHEMICALS LIMITED IN 500 055 Hyderabad
  • OLON S.P.A. IT 20090 Rodano
Geographically, this report splits the Global market into the following regions:
  • Asia Pacific
    • Japan
      • Tokyo
      • Yokohama
      • Osaka
      • Nagoya
      • Others
    • China
    • Korea
    • India
    • Others
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Russia
    • Others
  • North America
    • United States
    • Canada
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Southeast Asia
    • Singapore
    • Malaysia
    • Vietnam
    • Myanmar
    • Thailand
    • Indonesia
    • Philippines
    • Others
  • Middle East & Africa
    • Saudi Arabia
    • Iran
    • UAE
    • Turkey
    • Israel
    • Egypt
    • South Africa
    • Others
On the basis of product, the Urinary System Drugs market is primarily split into

Urinary System Drugs Market, by Loop diuretics
  • Furosemide
  • Bumetanide
  • Bumetanide
  • Ethacrynic Acid
  • Etozolin
  • Muzolimine
  • Piretanide
  • Ticrynafen
  • Torasemide
Urinary System Drugs Market, by Thiazide diuretic
  • Hydrochlorothiazide
  • Bendrofluazide
  • Hdyroflumethiazide
  • Polythiazide
  • Trichlormethiazide
  • Cyclopenthiazide
  • Methyclothiazide
  • Cyclothiazide
  • Mebutizide
Urinary System Drugs Market, by Thiazide-like diuretics
  • Quinethazone
  • Clopamide
  • Chlorthalidone
  • Mefruside
  • Clofenamide
  • Metolazone
  • Meticrane
  • Xipamide
  • Indapamide
  • Clorexolone
  • Fenquizone
Urinary System Drugs Market, by potassium-sparing diuretics
  • Amiloride
  • Triamterene
  • Spironolactone
  • Eplerenone
  • Canrenoate Potassium
  • Canrenone
Urinary System Drugs Market, by Vasopressin receptor antagoni
  • Conivaptan
  • Mozavaptan
  • Tolvaptan
  • Demeclocycline
Main Applications
  • Urology Surgery
  • department of nephropathy
  • Liver disease division
  • Hospital
  • Clinic


1 URINARY SYSTEM DRUGS OVERVIEW

1.1 Product Overview and Scope of Urinary System Drugs
1.2 Global and Japan Urinary System Drugs Market by Applications/End Users
  1.2.1 Japan Urinary System Drugs Sales () and Market Share Comparison by Applications (2012-2017)
    1.2.1.1 Japan Urinary System Drugs Sales () and Market Share by Applications (2012-2017)
    1.2.1.2 Japan Urinary System Drugs Sales Growth Rate (%) by Applications (2012-2017)
    1.2.1.3 Market Drivers and Opportunities
  1.2.2 Japan Urinary System Drugs Sales () and Market Share Comparison by Applications (2012-2017)
  1.2.3 Global Urinary System Drugs Sales by Application (2012-2017)
    1.2.3.1 Global Urinary System Drugs Sales () and Market Share by Applications (2012-2017)
    1.2.3.2 Global Urinary System Drugs Sales Growth Rate (%) by Applications (2012-2017)
    1.2.3.3 Market Drivers and Opportunities
  1.2.4 Global Urinary System Drugs Sales () and Market Share Comparison by Applications (2012-2017)
  1.2.5 Urology Surgery
  1.2.6 department of nephropathy
  1.2.7 Liver disease division
  1.2.8 Hospital
  1.2.9 Clinic
1.3 Global and Japan Market Size (Sales and Revenue) of Urinary System Drugs (2012-2017)
  1.3.1 Japan Market Size (Sales and Revenue) of Urinary System Drugs (2012-2017)
    1.3.1.1 Japan Urinary System Drugs Sales () and Growth Rate (%) (2012-2017)
    1.3.1.2 Japan Urinary System Drugs Revenue (Million USD) and Growth Rate (2012-2017)
  1.3.2 Global Market Size (Sales and Revenue) of Urinary System Drugs (2012-2017)
    1.3.2.1 Global Urinary System Drugs Sales () and Growth Rate (%) (2012-2017)
    1.3.2.2 Global Urinary System Drugs Revenue (Million USD) and Growth Rate (2012-2017)
1.4 Global and Japan Classification of Urinary System Drugs by Loop diuretics
  1.4.1 Japan Urinary System Drugs Sales () and Market Share by Loop diuretics (2012-2017)
  1.4.2 Global Urinary System Drugs Sales () and Market Share by Loop diuretics (2012-2017)
  1.4.3 Japan Urinary System Drugs Revenue (Million USD) and Market Share by Loop diuretics (2012-2017)
  1.4.4 Global Urinary System Drugs Revenue (Million USD) and Market Share by Loop diuretics (2012-2017)
  1.4.5 Japan Urinary System Drugs Price () by Loop diuretics (2012-2017)
  1.4.6 Global Urinary System Drugs Price () by Loop diuretics (2012-2017)
  1.4.7 Japan Urinary System Drugs Sales Growth Rate (%) by Loop diuretics (2012-2017)
  1.4.8 Global Urinary System Drugs Sales Growth Rate (%) by Loop diuretics (2012-2017)
  1.4.9 Furosemide
  1.4.10 Bumetanide
  1.4.11 Bumetanide
  1.4.12 Ethacrynic Acid
  1.4.13 Etozolin
1.5 Global and Japan Classification of Urinary System Drugs by Thiazide diuretic
  1.5.1 Japan Urinary System Drugs Sales () and Market Share by Thiazide diuretic (2012-2017)
  1.5.2 Global Urinary System Drugs Sales () and Market Share by Thiazide diuretic (2012-2017)
  1.5.3 Japan Urinary System Drugs Revenue (Million USD) and Market Share by Thiazide diuretic (2012-2017)
  1.5.4 Global Urinary System Drugs Revenue (Million USD) and Market Share by Thiazide diuretic (2012-2017)
  1.5.5 Japan Urinary System Drugs Price () by Thiazide diuretic (2012-2017)
  1.5.6 Global Urinary System Drugs Price () by Thiazide diuretic (2012-2017)
  1.5.7 Japan Urinary System Drugs Sales Growth Rate (%) by Thiazide diuretic (2012-2017)
  1.5.8 Global Urinary System Drugs Sales Growth Rate (%) by Thiazide diuretic (2012-2017)
  1.5.9 Hydrochlorothiazide
  1.5.10 Bendrofluazide
  1.5.11 Hdyroflumethiazide
  1.5.12 Polythiazide
  1.5.13 Trichlormethiazide
1.6 Global and Japan Classification of Urinary System Drugs by Thiazide-like diuretics
  1.6.1 Japan Urinary System Drugs Sales () and Market Share by Thiazide-like diuretics (2012-2017)
  1.6.2 Global Urinary System Drugs Sales () and Market Share by Thiazide-like diuretics (2012-2017)
  1.6.3 Japan Urinary System Drugs Revenue (Million USD) and Market Share by Thiazide-like diuretics (2012-2017)
  1.6.4 Global Urinary System Drugs Revenue (Million USD) and Market Share by Thiazide-like diuretics (2012-2017)
  1.6.5 Japan Urinary System Drugs Price () by Thiazide-like diuretics (2012-2017)
  1.6.6 Global Urinary System Drugs Price () by Thiazide-like diuretics (2012-2017)
  1.6.7 Japan Urinary System Drugs Sales Growth Rate (%) by Thiazide-like diuretics (2012-2017)
  1.6.8 Global Urinary System Drugs Sales Growth Rate (%) by Thiazide-like diuretics (2012-2017)
  1.6.9 Quinethazone
  1.6.10 Clopamide
  1.6.11 Chlorthalidone
  1.6.12 Mefruside
  1.6.13 Clofenamide
1.7 Global and Japan Classification of Urinary System Drugs by potassium-sparing diuretics
  1.7.1 Japan Urinary System Drugs Sales () and Market Share by potassium-sparing diuretics (2012-2017)
  1.7.2 Global Urinary System Drugs Sales () and Market Share by potassium-sparing diuretics (2012-2017)
  1.7.3 Japan Urinary System Drugs Revenue (Million USD) and Market Share by potassium-sparing diuretics (2012-2017)
  1.7.4 Global Urinary System Drugs Revenue (Million USD) and Market Share by potassium-sparing diuretics (2012-2017)
  1.7.5 Japan Urinary System Drugs Price () by potassium-sparing diuretics (2012-2017)
  1.7.6 Global Urinary System Drugs Price () by potassium-sparing diuretics (2012-2017)
  1.7.7 Japan Urinary System Drugs Sales Growth Rate (%) by potassium-sparing diuretics (2012-2017)
  1.7.8 Global Urinary System Drugs Sales Growth Rate (%) by potassium-sparing diuretics (2012-2017)
  1.7.9 Amiloride
  1.7.10 Triamterene
  1.7.11 Spironolactone
  1.7.12 Eplerenone
  1.7.13 Canrenoate Potassium
1.8 Global and Japan Classification of Urinary System Drugs by Vasopressin receptor antagonis
  1.8.1 Japan Urinary System Drugs Sales () and Market Share by Vasopressin receptor antagonis (2012-2017)
  1.8.2 Global Urinary System Drugs Sales () and Market Share by Vasopressin receptor antagonis (2012-2017)
  1.8.3 Japan Urinary System Drugs Revenue (Million USD) and Market Share by Vasopressin receptor antagonis (2012-2017)
  1.8.4 Global Urinary System Drugs Revenue (Million USD) and Market Share by Vasopressin receptor antagonis (2012-2017)
  1.8.5 Japan Urinary System Drugs Price () by Vasopressin receptor antagonis (2012-2017)
  1.8.6 Global Urinary System Drugs Price () by Vasopressin receptor antagonis (2012-2017)
  1.8.7 Japan Urinary System Drugs Sales Growth Rate (%) by Vasopressin receptor antagonis (2012-2017)
  1.8.8 Global Urinary System Drugs Sales Growth Rate (%) by Vasopressin receptor antagonis (2012-2017)
  1.8.9 Conivaptan
  1.8.10 Mozavaptan
  1.8.11 Tolvaptan
  1.8.12 Demeclocycline

2 GLOBAL AND JAPAN URINARY SYSTEM DRUGS MARKET COMPETITION BY PLAYERS/MANUFACTURERS

2.1 Japan Urinary System Drugs Market Competition by Players/Manufacturers
  2.1.1 Japan Urinary System Drugs Sales and Market Share of Key Players/Manufacturers (2012-2017)
  2.1.2 Japan Urinary System Drugs Revenue and Share by Players/Manufacturers (2012-2017)
  2.1.3 Japan Urinary System Drugs Average Price () by Players/Manufacturers (2012-2017)
  2.1.4 Japan Urinary System Drugs Market Competitive Situation and Trends
    2.1.4.1 Japan Urinary System Drugs Market Concentration Rate
    2.1.4.2 Japan Urinary System Drugs Market Share of Top 3 and Top 5 Players/Manufacturers
    2.1.4.3 Mergers & Acquisitions, Expansion in Japan Market
  2.1.5 Japan Players/Manufacturers Urinary System Drugs Manufacturing Base Distribution, Sales Area, Product Types
2.2 Global Urinary System Drugs Market Competition by Players/Manufacturers
  2.2.1 Global Urinary System Drugs Sales and Market Share of Key Players/Manufacturers (2012-2017)
  2.2.2 Global Urinary System Drugs Revenue and Share by Players/Manufacturers (2012-2017)
  2.2.3 Global Urinary System Drugs Average Price () by Players/Manufacturers (2012-2017)
  2.2.4 Global Urinary System Drugs Market Competitive Situation and Trends
    2.2.4.1 Global Urinary System Drugs Market Concentration Rate
    2.2.4.2 Global Urinary System Drugs Market Share of Top 3 and Top 5 Players/Manufacturers
    2.2.4.3 Mergers & Acquisitions, Expansion in Global Market
  2.2.5 Global Players/Manufacturers Urinary System Drugs Manufacturing Base Distribution, Sales Area, Product Types

3 GLOBAL AND JAPAN URINARY SYSTEM DRUGS SALES AND REVENUE BY REGIONS (2012-2017)

3.1 Asia Pacific Urinary System Drugs Sales and Revenue by Regions (2012-2017)
  3.1.1 Japan Urinary System Drugs Sales and Revenue (2012-2017)
    3.1.1.1 Japan Urinary System Drugs Sales () and Market Share (2012-2017)
    3.1.1.2 Japan Urinary System Drugs Revenue (Million USD) and Market Share (2012-2017)
    3.1.1.3 Japan Urinary System Drugs Price ()(2012-2017)
  3.1.2 China Urinary System Drugs Sales and Revenue (2012-2017)
    3.1.2.1 China Urinary System Drugs Sales () and Market Share (2012-2017)
    3.1.2.2 China Urinary System Drugs Revenue (Million USD) and Market Share (2012-2017)
    3.1.2.3 China Urinary System Drugs Price ()(2012-2017)
  3.1.3 Korea Urinary System Drugs Sales and Revenue (2012-2017)
    3.1.3.1 Korea Urinary System Drugs Sales () and Market Share (2012-2017)
    3.1.3.2 Korea Urinary System Drugs Revenue (Million USD) and Market Share (2012-2017)
    3.1.3.3 Korea Urinary System Drugs Price ()(2012-2017)
  3.1.4 India Urinary System Drugs Sales and Revenue (2012-2017)
    3.1.4.1 India Urinary System Drugs Sales () and Market Share (2012-2017)
    3.1.4.2 India Urinary System Drugs Revenue (Million USD) and Market Share (2012-2017)
    3.1.4.3 India Urinary System Drugs Price ()(2012-2017)
  3.1.5 Others Urinary System Drugs Sales and Revenue (2012-2017)
    3.1.5.1 Others Urinary System Drugs Sales () and Market Share (2012-2017)
    3.1.5.2 Others Urinary System Drugs Revenue (Million USD) and Market Share (2012-2017)
    3.1.5.3 Others Urinary System Drugs Price ()(2012-2017)
3.2 Europe Urinary System Drugs Sales and Revenue by Regions (2012-2017)
  3.2.1 France Urinary System Drugs Sales and Revenue (2012-2017)
    3.2.1.1 France Urinary System Drugs Sales () and Market Share (2012-2017)
    3.2.1.2 France Urinary System Drugs Revenue (Million USD) and Market Share (2012-2017)
    3.2.1.3 France Urinary System Drugs Price ()(2012-2017)
  3.2.2 Germany Urinary System Drugs Sales and Revenue (2012-2017)
    3.2.2.1 Germany Urinary System Drugs Sales () and Market Share (2012-2017)
    3.2.2.2 Germany Urinary System Drugs Revenue (Million USD) and Market Share (2012-2017)
    3.2.2.3 Germany Urinary System Drugs Price ()(2012-2017)
  3.2.3 United Kingdom Urinary System Drugs Sales and Revenue (2012-2017)
    3.2.3.1 United Kingdom Urinary System Drugs Sales () and Market Share (2012-2017)
    3.2.3.2 United Kingdom Urinary System Drugs Revenue (Million USD) and Market Share (2012-2017)
    3.2.3.3 United Kingdom Urinary System Drugs Price ()(2012-2017)
  3.2.4 Italy Urinary System Drugs Sales and Revenue (2012-2017)
    3.2.4.1 Italy Urinary System Drugs Sales () and Market Share (2012-2017)
    3.2.4.2 Italy Urinary System Drugs Revenue (Million USD) and Market Share (2012-2017)
    3.2.4.3 Italy Urinary System Drugs Price ()(2012-2017)
  3.2.5 Russia Urinary System Drugs Sales and Revenue (2012-2017)
    3.2.5.1 Russia Urinary System Drugs Sales () and Market Share (2012-2017)
    3.2.5.2 Russia Urinary System Drugs Revenue (Million USD) and Market Share (2012-2017)
    3.2.5.3 Russia Urinary System Drugs Price ()(2012-2017)
  3.2.6 Others Urinary System Drugs Sales and Revenue (2012-2017)
    3.2.6.1 Others Urinary System Drugs Sales () and Market Share (2012-2017)
    3.2.6.2 Others Urinary System Drugs Revenue (Million USD) and Market Share (2012-2017)
    3.2.6.3 Others Urinary System Drugs Price ()(2012-2017)
3.3 North America Urinary System Drugs Sales and Revenue by Regions (2012-2017)
  3.3.1 United States Urinary System Drugs Sales and Revenue (2012-2017)
    3.3.1.1 United States Urinary System Drugs Sales () and Market Share (2012-2017)
    3.3.1.2 United States Urinary System Drugs Revenue (Million USD) and Market Share (2012-2017)
    3.3.1.3 United States Urinary System Drugs Price ()(2012-2017)
  3.3.2 Canada Urinary System Drugs Sales and Revenue (2012-2017)
    3.3.2.1 Canada Urinary System Drugs Sales () and Market Share (2012-2017)
    3.3.2.2 Canada Urinary System Drugs Revenue (Million USD) and Market Share (2012-2017)
    3.3.2.3 Canada Urinary System Drugs Price ()(2012-2017)
3.4 Latin America Urinary System Drugs Sales and Revenue by Regions (2012-2017)
  3.4.1 Brazil Urinary System Drugs Sales and Revenue (2012-2017)
    3.4.1.1 Brazil Urinary System Drugs Sales () and Market Share (2012-2017)
    3.4.1.2 Brazil Urinary System Drugs Revenue (Million USD) and Market Share (2012-2017)
    3.4.1.3 Brazil Urinary System Drugs Price ()(2012-2017)
  3.4.2 Mexico Urinary System Drugs Sales and Revenue (2012-2017)
    3.4.2.1 Mexico Urinary System Drugs Sales () and Market Share (2012-2017)
    3.4.2.2 Mexico Urinary System Drugs Revenue (Million USD) and Market Share (2012-2017)
    3.4.2.3 Mexico Urinary System Drugs Price ()(2012-2017)
  3.4.3 Others Urinary System Drugs Sales and Revenue (2012-2017)
    3.4.3.1 Others Urinary System Drugs Sales () and Market Share (2012-2017)
    3.4.3.2 Others Urinary System Drugs Revenue (Million USD) and Market Share (2012-2017)
    3.4.3.3 Others Urinary System Drugs Price ()(2012-2017)
3.5 Southeast Asia Urinary System Drugs Sales and Revenue by Regions (2012-2017)
  3.5.1 Singapore Urinary System Drugs Sales and Revenue (2012-2017)
    3.5.1.1 Singapore Urinary System Drugs Sales () and Market Share (2012-2017)
    3.5.1.2 Singapore Urinary System Drugs Revenue (Million USD) and Market Share (2012-2017)
    3.5.1.3 Singapore Urinary System Drugs Price ()(2012-2017)
  3.5.2 Malaysia Urinary System Drugs Sales and Revenue (2012-2017)
    3.5.2.1 Malaysia Urinary System Drugs Sales () and Market Share (2012-2017)
    3.5.2.2 Malaysia Urinary System Drugs Revenue (Million USD) and Market Share (2012-2017)
    3.5.2.3 Malaysia Urinary System Drugs Price ()(2012-2017)
  3.5.3 Vietnam Urinary System Drugs Sales and Revenue (2012-2017)
    3.5.3.1 Vietnam Urinary System Drugs Sales () and Market Share (2012-2017)
    3.5.3.2 Vietnam Urinary System Drugs Revenue (Million USD) and Market Share (2012-2017)
    3.5.3.3 Vietnam Urinary System Drugs Price ()(2012-2017)
  3.5.4 Myanmar Urinary System Drugs Sales and Revenue (2012-2017)
    3.5.4.1 Myanmar Urinary System Drugs Sales () and Market Share (2012-2017)
    3.5.4.2 Myanmar Urinary System Drugs Revenue (Million USD) and Market Share (2012-2017)
    3.5.4.3 Myanmar Urinary System Drugs Price ()(2012-2017)
  3.5.5 Thailand Urinary System Drugs Sales and Revenue (2012-2017)
    3.5.5.1 Thailand Urinary System Drugs Sales () and Market Share (2012-2017)
    3.5.5.2 Thailand Urinary System Drugs Revenue (Million USD) and Market Share (2012-2017)
    3.5.5.3 Thailand Urinary System Drugs Price ()(2012-2017)
  3.5.6 Indonesia Urinary System Drugs Sales and Revenue (2012-2017)
    3.5.6.1 Indonesia Urinary System Drugs Sales () and Market Share (2012-2017)
    3.5.6.2 Indonesia Urinary System Drugs Revenue (Million USD) and Market Share (2012-2017)
    3.5.6.3 Indonesia Urinary System Drugs Price ()(2012-2017)
  3.5.7 Philippines Urinary System Drugs Sales and Revenue (2012-2017)
    3.5.7.1 Philippines Urinary System Drugs Sales () and Market Share (2012-2017)
    3.5.7.2 Philippines Urinary System Drugs Revenue (Million USD) and Market Share (2012-2017)
    3.5.7.3 Philippines Urinary System Drugs Price ()(2012-2017)
  3.5.8 Others Urinary System Drugs Sales and Revenue (2012-2017)
    3.5.8.1 Others Urinary System Drugs Sales () and Market Share (2012-2017)
    3.5.8.2 Others Urinary System Drugs Revenue (Million USD) and Market Share (2012-2017)
    3.5.8.3 Others Urinary System Drugs Price ()(2012-2017)
3.6 Middle East & Africa Urinary System Drugs Sales and Revenue by Regions (2012-2017)
  3.6.1 Saudi Arabia Urinary System Drugs Sales and Revenue (2012-2017)
    3.6.1.1 Saudi Arabia Urinary System Drugs Sales () and Market Share (2012-2017)
    3.6.1.2 Saudi Arabia Urinary System Drugs Revenue (Million USD) and Market Share (2012-2017)
    3.6.1.3 Saudi Arabia Urinary System Drugs Price ()(2012-2017)
  3.6.2 Iran Urinary System Drugs Sales and Revenue (2012-2017)
    3.6.2.1 Iran Urinary System Drugs Sales () and Market Share (2012-2017)
    3.6.2.2 Iran Urinary System Drugs Revenue (Million USD) and Market Share (2012-2017)
    3.6.2.3 Iran Urinary System Drugs Price ()(2012-2017)
  3.6.3 UAE Urinary System Drugs Sales and Revenue (2012-2017)
    3.6.3.1 UAE Urinary System Drugs Sales () and Market Share (2012-2017)
    3.6.3.2 UAE Urinary System Drugs Revenue (Million USD) and Market Share (2012-2017)
    3.6.3.3 UAE Urinary System Drugs Price ()(2012-2017)
  3.6.4 Turkey Urinary System Drugs Sales and Revenue (2012-2017)
    3.6.4.1 Turkey Urinary System Drugs Sales () and Market Share (2012-2017)
    3.6.4.2 Turkey Urinary System Drugs Revenue (Million USD) and Market Share (2012-2017)
    3.6.4.3 Turkey Urinary System Drugs Price ()(2012-2017)
  3.6.5 Israel Urinary System Drugs Sales and Revenue (2012-2017)
    3.6.5.1 Israel Urinary System Drugs Sales () and Market Share (2012-2017)
    3.6.5.2 Israel Urinary System Drugs Revenue (Million USD) and Market Share (2012-2017)
    3.6.5.3 Israel Urinary System Drugs Price ()(2012-2017)
  3.6.6 Egypt Urinary System Drugs Sales and Revenue (2012-2017)
    3.6.6.1 Egypt Urinary System Drugs Sales () and Market Share (2012-2017)
    3.6.6.2 Egypt Urinary System Drugs Revenue (Million USD) and Market Share (2012-2017)
    3.6.6.3 Egypt Urinary System Drugs Price ()(2012-2017)
  3.6.7 South Africa Urinary System Drugs Sales and Revenue (2012-2017)
    3.6.7.1 South Africa Urinary System Drugs Sales () and Market Share (2012-2017)
    3.6.7.2 South Africa Urinary System Drugs Revenue (Million USD) and Market Share (2012-2017)
    3.6.7.3 South Africa Urinary System Drugs Price ()(2012-2017)
  3.6.8 Others Urinary System Drugs Sales and Revenue (2012-2017)
    3.6.8.1 Others Urinary System Drugs Sales () and Market Share (2012-2017)
    3.6.8.2 Others Urinary System Drugs Revenue (Million USD) and Market Share (2012-2017)
    3.6.8.3 Others Urinary System Drugs Price ()(2012-2017)

4 GLOBAL AND JAPAN URINARY SYSTEM DRUGS PLAYERS/MANUFACTURERS PROFILES AND SALES DATA

4.1 ALEMBIC PHARMACEUTICALS LIMITED IN 390 003 Vadodara
  4.1.1 Company Basic Information, Manufacturing Base and Competitors
  4.1.2 Urinary System Drugs Product Category, Application and Specification
    4.1.2.1 Product A
    4.1.2.2 Product B
  4.1.3 ALEMBIC PHARMACEUTICALS LIMITED IN 390 003 Vadodara Urinary System Drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
  4.1.4 Main Business/Business Overview
4.2 AMRI INDIA PRIVATE LIMITED IN 431 136 Aurangabad
  4.2.1 Company Basic Information, Manufacturing Base and Competitors
  4.2.2 Urinary System Drugs Product Category, Application and Specification
    4.2.2.1 Product A
    4.2.2.2 Product B
  4.2.3 AMRI INDIA PRIVATE LIMITED IN 431 136 Aurangabad Urinary System Drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
  4.2.4 Main Business/Business Overview
4.3 AREVIPHARMA GMBH DE 01445 Radebeul
  4.3.1 Company Basic Information, Manufacturing Base and Competitors
  4.3.2 Urinary System Drugs Product Category, Application and Specification
    4.3.2.1 Product A
    4.3.2.2 Product B
  4.3.3 AREVIPHARMA GMBH DE 01445 Radebeul Urinary System Drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
  4.3.4 Main Business/Business Overview
4.4 AURISCO PHARMACEUTICAL CO., LTD. CN 317 200 Tiantai
  4.4.1 Company Basic Information, Manufacturing Base and Competitors
  4.4.2 Urinary System Drugs Product Category, Application and Specification
    4.4.2.1 Product A
    4.4.2.2 Product B
  4.4.3 AURISCO PHARMACEUTICAL CO., LTD. CN 317 200 Tiantai Urinary System Drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
  4.4.4 Main Business/Business Overview
4.5 AUROBINDO PHARMA LIMITED IN 500 038 Hyderabad
  4.5.1 Company Basic Information, Manufacturing Base and Competitors
  4.5.2 Urinary System Drugs Product Category, Application and Specification
    4.5.2.1 Product A
    4.5.2.2 Product B
  4.5.3 AUROBINDO PHARMA LIMITED IN 500 038 Hyderabad Urinary System Drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
  4.5.4 Main Business/Business Overview
4.6 Bioindustria L.I.M. S.p.A. IT 15067 Novi Ligure
  4.6.1 Company Basic Information, Manufacturing Base and Competitors
  4.6.2 Urinary System Drugs Product Category, Application and Specification
    4.6.2.1 Product A
    4.6.2.2 Product B
  4.6.3 Bioindustria L.I.M. S.p.A. IT 15067 Novi Ligure Urinary System Drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
  4.6.4 Main Business/Business Overview
4.7 BLUE CIRCLE ORGANICS PRIVATE LIMITED IN 421 501 Ambernath West
  4.7.1 Company Basic Information, Manufacturing Base and Competitors
  4.7.2 Urinary System Drugs Product Category, Application and Specification
    4.7.2.1 Product A
    4.7.2.2 Product B
  4.7.3 BLUE CIRCLE ORGANICS PRIVATE LIMITED IN 421 501 Ambernath West Urinary System Drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
  4.7.4 Main Business/Business Overview
4.8 Cambrex Charles City, Inc. US 50616-3466 Charles City
  4.8.1 Company Basic Information, Manufacturing Base and Competitors
  4.8.2 Urinary System Drugs Product Category, Application and Specification
    4.8.2.1 Product A
    4.8.2.2 Product B
  4.8.3 Cambrex Charles City, Inc. US 50616-3466 Charles City Urinary System Drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
  4.8.4 Main Business/Business Overview
4.9 CARGILL S.R.L. DIVISIONE AMIDI DERIVATI SPECIALITA IT 45035 Castelmassa
  4.9.1 Company Basic Information, Manufacturing Base and Competitors
  4.9.2 Urinary System Drugs Product Category, Application and Specification
    4.9.2.1 Product A
    4.9.2.2 Product B
  4.9.3 CARGILL S.R.L. DIVISIONE AMIDI DERIVATI SPECIALITA IT 45035 Castelmassa Urinary System Drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
  4.9.4 Main Business/Business Overview
4.10 CKD BIO CORPORATION KR 15604 Ansan-si
  4.10.1 Company Basic Information, Manufacturing Base and Competitors
  4.10.2 Urinary System Drugs Product Category, Application and Specification
    4.10.2.1 Product A
    4.10.2.2 Product B
  4.10.3 CKD BIO CORPORATION KR 15604 Ansan-si Urinary System Drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
  4.10.4 Main Business/Business Overview
4.11 Cosma S.p.A. IT 24040 Ciserano
4.12 CSPC INNOVATION PHARMACEUTICAL CO., LTD. CN 051 430 Shijiazhuang City
4.13 CTX LIFE SCIENCES PVT. LIMITED IN 394 230 Surat
4.14 EDMOND PHARMA S.R.L. IT 20037 Paderno Dugnano
4.15 F Hoffmann-La Roche Ltd. CH 4070 Basel
4.16 F.I.S. Fabbrica Italiana Sintetici S.p.A. IT 36075 Montecchio Maggiore
4.17 FLAMMA S.P.A. IT 24040 Chignolo d'Isola
4.18 G.D. Searle LLC US 10017 New York City
4.19 Gedeon Richter Plc. HU 1103 Budapest
4.20 HARMAN FINOCHEM LIMITED IN 400 098 Mumbai
4.21 HUBEI BIOCAUSE PHARMACEUTICAL CO., LTD. CN 448 000 Jingmen City
4.22 Industriale Chimica S.R.L. IT 21047 Saronno
4.23 IPCA Laboratories Limited IN 400 067 Mumbai
4.24 Laboratori Alchemia Srl IT 20134 Milano
4.25 MEDILUX LABORATORIES PRIVATE LIMITED IN 454 775 Pithampur
4.26 Micronised SANOFI CHIMIE FR 94250 Gentilly
4.27 Moehs Iberica S.L. ES 08191 Rubi
4.28 MSN LABORATORIES PRIVATE LIMITED IN 502 329 Rudraram Village
4.29 NAKODA CHEMICALS LIMITED IN 500 055 Hyderabad
4.30 OLON S.P.A. IT 20090 Rodano

5 URINARY SYSTEM DRUGS MANUFACTURING COST ANALYSIS

5.1 Urinary System Drugs Key Raw Materials Analysis
  5.1.1 Key Raw Materials
  5.1.2 Price Trend of Key Raw Materials
  5.1.3 Key Suppliers of Raw Materials
  5.1.4 Market Concentration Rate of Raw Materials
5.2 Proportion of Manufacturing Cost Structure
  5.2.1 Raw Materials
  5.2.2 Labor Cost
  5.2.3 Manufacturing Expenses
5.3 Manufacturing Process Analysis of Urinary System Drugs

6 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

6.1 Urinary System Drugs Industrial Chain Analysis
6.2 Upstream Raw Materials Sourcing
6.3 Raw Materials Sources of Urinary System Drugs Major Players/Manufacturers in 2016
6.4 Downstream Buyers

7 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

7.1 Marketing Channel
  7.1.1 Direct Marketing
  7.1.2 Indirect Marketing
  7.1.3 Marketing Channel Development Trend
7.2 Market Positioning
  7.2.1 Pricing Strategy
  7.2.2 Brand Strategy
  7.2.3 Target Client
7.3 Distributors/Traders List

8 MARKET EFFECT FACTORS ANALYSIS

8.1 Technology Progress/Risk
  8.1.1 Substitutes Threat
  8.1.2 Technology Progress in Related Industry
8.2 Consumer Needs/Customer Preference Change
8.3 Economic/Political Environmental Change

9 GLOBAL AND JAPAN URINARY SYSTEM DRUGS MARKET SIZE (SALES AND REVENUE) FORECAST (2017-2022)

9.1 Global and Japan Urinary System Drugs Sales (), Revenue (Million USD) Forecast (2017-2022)
9.2 Global and Japan Urinary System Drugs Sales () Forecast by Type (2017-2022)
  9.2.1 by Loop diuretics
  9.2.2 by Thiazide diuretic
  9.2.3 by Thiazide-like diuretics
  9.2.4 by potassium-sparing diuretics
  9.2.5 by Vasopressin receptor antagonis
9.3 Global and Japan Urinary System Drugs Sales () Forecast by Application (2017-2022)
9.4 Global and Japan Urinary System Drugs Sales () Forecast by Regions (2017-2022)

10 RESEARCH FINDINGS AND CONCLUSION

11 METHODOLOGY AND DATA SOURCE

11.1 Methodology/Research Approach
  11.1.1 Research Programs/Design
  11.1.2 Market Size Estimation
  11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
  11.2.1 Secondary Sources
  11.2.2 Primary Sources
11.3 Disclaimer
11.4 Author List
LIST OF TABLES AND FIGURES

Figure Product Picture of Urinary System Drugs
Table Japan Urinary System Drugs Sales (Million Units) Comparison by Applications (2012-2017)
Figure Japan Sales Market Share (%) of Urinary System Drugs by Applications in 2016
Table Global Urinary System Drugs Sales (Million Units) Comparison by Applications (2012-2017)
Figure Global Sales Market Share (%) of Urinary System Drugs by Applications in 2016
Figure Urology Surgery Examples
Table Key Downstream Customer in Urology Surgery
Figure department of nephropathy Examples
Table Key Downstream Customer in department of nephropathy
Figure Liver disease division Examples
Table Key Downstream Customer in Liver disease division
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Furosemide Product Picture
Figure Bumetanide Product Picture
Figure Bumetanide Product Picture
Figure Ethacrynic Acid Product Picture
Figure Etozolin Product Picture
Figure Hydrochlorothiazide Product Picture
Figure Bendrofluazide Product Picture
Figure Hdyroflumethiazide Product Picture
Figure Polythiazide Product Picture
Figure Trichlormethiazide Product Picture
Figure Quinethazone Product Picture
Figure Clopamide Product Picture
Figure Chlorthalidone Product Picture
Figure Mefruside Product Picture
Figure Clofenamide Product Picture
Figure Amiloride Product Picture
Figure Triamterene Product Picture
Figure Spironolactone Product Picture
Figure Eplerenone Product Picture
Figure Canrenoate Potassium Product Picture
Figure Mozavaptan Product Picture
Figure Tolvaptan Product Picture
Figure Demeclocycline Product Picture
Table ALEMBIC PHARMACEUTICALS LIMITED IN 390 003 Vadodara Basic Information List
Table ALEMBIC PHARMACEUTICALS LIMITED IN 390 003 Vadodara Urinary System Drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Table ALEMBIC PHARMACEUTICALS LIMITED IN 390 003 Vadodara Urinary System Drugs Sales Growth Rate (%)(2012-2017)
Table ALEMBIC PHARMACEUTICALS LIMITED IN 390 003 Vadodara Urinary System Drugs Sales Market Share (%) in Japan (2012-2017)
Figure ALEMBIC PHARMACEUTICALS LIMITED IN 390 003 Vadodara Urinary System Drugs Revenue Market Share (%) in Japan (2012-2017)
Table AMRI INDIA PRIVATE LIMITED IN 431 136 Aurangabad Basic Information List
Table AMRI INDIA PRIVATE LIMITED IN 431 136 Aurangabad Urinary System Drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Table AMRI INDIA PRIVATE LIMITED IN 431 136 Aurangabad Urinary System Drugs Sales Growth Rate (%)(2012-2017)
Table AMRI INDIA PRIVATE LIMITED IN 431 136 Aurangabad Urinary System Drugs Sales Market Share (%) in Japan (2012-2017)
Figure AMRI INDIA PRIVATE LIMITED IN 431 136 Aurangabad Urinary System Drugs Revenue Market Share (%) in Japan (2012-2017)
Table AREVIPHARMA GMBH DE 01445 Radebeul Basic Information List
Table AREVIPHARMA GMBH DE 01445 Radebeul Urinary System Drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Table AREVIPHARMA GMBH DE 01445 Radebeul Urinary System Drugs Sales Growth Rate (%)(2012-2017)
Table AREVIPHARMA GMBH DE 01445 Radebeul Urinary System Drugs Sales Market Share (%) in Japan (2012-2017)
Figure AREVIPHARMA GMBH DE 01445 Radebeul Urinary System Drugs Revenue Market Share (%) in Japan (2012-2017)
Table AURISCO PHARMACEUTICAL CO., LTD. CN 317 200 Tiantai Basic Information List
Table AURISCO PHARMACEUTICAL CO., LTD. CN 317 200 Tiantai Urinary System Drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Table AURISCO PHARMACEUTICAL CO., LTD. CN 317 200 Tiantai Urinary System Drugs Sales Growth Rate (%)(2012-2017)
Table AURISCO PHARMACEUTICAL CO., LTD. CN 317 200 Tiantai Urinary System Drugs Sales Market Share (%) in Japan (2012-2017)
Figure AURISCO PHARMACEUTICAL CO., LTD. CN 317 200 Tiantai Urinary System Drugs Revenue Market Share (%) in Japan (2012-2017)
Table AUROBINDO PHARMA LIMITED IN 500 038 Hyderabad Basic Information List
Table AUROBINDO PHARMA LIMITED IN 500 038 Hyderabad Urinary System Drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Table AUROBINDO PHARMA LIMITED IN 500 038 Hyderabad Urinary System Drugs Sales Growth Rate (%)(2012-2017)
Table AUROBINDO PHARMA LIMITED IN 500 038 Hyderabad Urinary System Drugs Sales Market Share (%) in Japan (2012-2017)
Figure AUROBINDO PHARMA LIMITED IN 500 038 Hyderabad Urinary System Drugs Revenue Market Share (%) in Japan (2012-2017)
Table Bioindustria L.I.M. S.p.A. IT 15067 Novi Ligure Basic Information List
Table Bioindustria L.I.M. S.p.A. IT 15067 Novi Ligure Urinary System Drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Table Bioindustria L.I.M. S.p.A. IT 15067 Novi Ligure Urinary System Drugs Sales Growth Rate (%)(2012-2017)
Table Bioindustria L.I.M. S.p.A. IT 15067 Novi Ligure Urinary System Drugs Sales Market Share (%) in Japan (2012-2017)
Figure Bioindustria L.I.M. S.p.A. IT 15067 Novi Ligure Urinary System Drugs Revenue Market Share (%) in Japan (2012-2017)
Table BLUE CIRCLE ORGANICS PRIVATE LIMITED IN 421 501 Ambernath West Basic Information List
Table BLUE CIRCLE ORGANICS PRIVATE LIMITED IN 421 501 Ambernath West Urinary System Drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Table BLUE CIRCLE ORGANICS PRIVATE LIMITED IN 421 501 Ambernath West Urinary System Drugs Sales Growth Rate (%)(2012-2017)
Table BLUE CIRCLE ORGANICS PRIVATE LIMITED IN 421 501 Ambernath West Urinary System Drugs Sales Market Share (%) in Japan (2012-2017)
Figure BLUE CIRCLE ORGANICS PRIVATE LIMITED IN 421 501 Ambernath West Urinary System Drugs Revenue Market Share (%) in Japan (2012-2017)
Table Cambrex Charles City, Inc. US 50616-3466 Charles City Basic Information List
Table Cambrex Charles City, Inc. US 50616-3466 Charles City Urinary System Drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Table Cambrex Charles City, Inc. US 50616-3466 Charles City Urinary System Drugs Sales Growth Rate (%)(2012-2017)
Table Cambrex Charles City, Inc. US 50616-3466 Charles City Urinary System Drugs Sales Market Share (%) in Japan (2012-2017)
Figure Cambrex Charles City, Inc. US 50616-3466 Charles City Urinary System Drugs Revenue Market Share (%) in Japan (2012-2017)
Table CARGILL S.R.L. DIVISIONE AMIDI DERIVATI SPECIALITA IT 45035 Castelmassa Basic Information List
Table CARGILL S.R.L. DIVISIONE AMIDI DERIVATI SPECIALITA IT 45035 Castelmassa Urinary System Drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Table CARGILL S.R.L. DIVISIONE AMIDI DERIVATI SPECIALITA IT 45035 Castelmassa Urinary System Drugs Sales Growth Rate (%)(2012-2017)
Table CARGILL S.R.L. DIVISIONE AMIDI DERIVATI SPECIALITA IT 45035 Castelmassa Urinary System Drugs Sales Market Share (%) in Japan (2012-2017)
Figure CARGILL S.R.L. DIVISIONE AMIDI DERIVATI SPECIALITA IT 45035 Castelmassa Urinary System Drugs Revenue Market Share (%) in Japan (2012-2017)
Table CKD BIO CORPORATION KR 15604 Ansan-si Basic Information List
Table CKD BIO CORPORATION KR 15604 Ansan-si Urinary System Drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Table CKD BIO CORPORATION KR 15604 Ansan-si Urinary System Drugs Sales Growth Rate (%)(2012-2017)
Table CKD BIO CORPORATION KR 15604 Ansan-si Urinary System Drugs Sales Market Share (%) in Japan (2012-2017)
Figure CKD BIO CORPORATION KR 15604 Ansan-si Urinary System Drugs Revenue Market Share (%) in Japan (2012-2017)
Table Cosma S.p.A. IT 24040 Ciserano Basic Information List
Table CSPC INNOVATION PHARMACEUTICAL CO., LTD. CN 051 430 Shijiazhuang City Basic Information List
Table CTX LIFE SCIENCES PVT. LIMITED IN 394 230 Surat Basic Information List
Table EDMOND PHARMA S.R.L. IT 20037 Paderno Dugnano Basic Information List
Table F Hoffmann-La Roche Ltd. CH 4070 Basel Basic Information List
Table F.I.S. Fabbrica Italiana Sintetici S.p.A. IT 36075 Montecchio Maggiore Basic Information List
Table FLAMMA S.P.A. IT 24040 Chignolo d'Isola Basic Information List
Table G.D. Searle LLC US 10017 New York City Basic Information List
Table Gedeon Richter Plc. HU 1103 Budapest Basic Information List
Table HARMAN FINOCHEM LIMITED IN 400 098 Mumbai Basic Information List
Table HUBEI BIOCAUSE PHARMACEUTICAL CO., LTD. CN 448 000 Jingmen City Basic Information List
Table Industriale Chimica S.R.L. IT 21047 Saronno Basic Information List
Table IPCA Laboratories Limited IN 400 067 Mumbai Basic Information List
Table Laboratori Alchemia Srl IT 20134 Milano Basic Information List
Table MEDILUX LABORATORIES PRIVATE LIMITED IN 454 775 Pithampur Basic Information List
Table Micronised SANOFI CHIMIE FR 94250 Gentilly Basic Information List
Table Moehs Iberica S.L. ES 08191 Rubi Basic Information List
Table MSN LABORATORIES PRIVATE LIMITED IN 502 329 Rudraram Village Basic Information List
Table NAKODA CHEMICALS LIMITED IN 500 055 Hyderabad Basic Information List
Table OLON S.P.A. IT 20090 Rodano Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Urinary System Drugs
Figure Manufacturing Process Analysis of Urinary System Drugs
Figure Urinary System Drugs Industrial Chain Analysis
Table Raw Materials Sources of Urinary System Drugs Major Players/Manufacturers in 2016
Table Major Buyers of Urinary System Drugs
Table Distributors/Traders List
Figure Japan Urinary System Drugs Sales () and Growth Rate (%) Forecast (2017-2022)
Figure Japan Urinary System Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Urinary System Drugs Price () Trend Forecast (2017-2022)
Figure Global Urinary System Drugs Sales () and Growth Rate (%) Forecast (2017-2022)
Figure Global Urinary System Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Urinary System Drugs Price () Trend Forecast (2017-2022)
Table Japan Urinary System Drugs Sales () Forecast by Type (2017-2022)
Table Global Urinary System Drugs Sales () Forecast by Type (2017-2022)
Figure Japan Urinary System Drugs Sales () Forecast by Type (2017-2022)
Figure Global Urinary System Drugs Sales () Forecast by Type (2017-2022)
Figure Japan Urinary System Drugs Sales Volume Market Share Forecast by Type in 2017
Figure Global Urinary System Drugs Sales Volume Market Share Forecast by Type in 2017
Table Japan Urinary System Drugs Sales () Forecast by Application (2017-2022)
Figure Japan Urinary System Drugs Sales Volume Market Share Forecast by Application (2017-2022)
Figure Japan Urinary System Drugs Sales Volume Market Share Forecast by Application in 2017
Table Global Urinary System Drugs Sales () Forecast by Application (2017-2022)
Figure Global Urinary System Drugs Sales Volume Market Share Forecast by Application (2017-2022)
Figure Global Urinary System Drugs Sales Volume Market Share Forecast by Application in 2017
Table Japan Urinary System Drugs Sales () Forecast by Regions (2017-2022)
Table Japan Urinary System Drugs Sales Volume Share Forecast by Regions (2017-2022)
Figure Japan Urinary System Drugs Sales Volume Share Forecast by Regions (2017-2022)
Table Global Urinary System Drugs Sales () Forecast by Regions (2017-2022)
Table Global Urinary System Drugs Sales Volume Share Forecast by Regions (2017-2022)
Figure Global Urinary System Drugs Sales Volume Share Forecast by Regions (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories